RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 1 filers reported holding RAPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,698 | -77.3% | 764 | -74.5% | 0.00% | -100.0% |
| Q2 2023 | $55,988 | +151218.9% | 2,994 | +46.7% | 0.00% | +100.0% |
| Q1 2023 | $37 | -68.6% | 2,041 | -65.6% | 0.00% | -80.0% |
| Q4 2022 | $118 | -99.9% | 5,926 | -15.0% | 0.01% | +66.7% |
| Q3 2022 | $168,000 | +630.4% | 6,973 | +441.4% | 0.00% | +200.0% |
| Q2 2022 | $23,000 | -37.8% | 1,288 | -23.1% | 0.00% | – |
| Q1 2022 | $37,000 | -69.9% | 1,674 | -49.9% | 0.00% | -100.0% |
| Q4 2021 | $123,000 | +207.5% | 3,339 | +158.0% | 0.00% | +100.0% |
| Q3 2021 | $40,000 | +14.3% | 1,294 | +17.6% | 0.00% | 0.0% |
| Q2 2021 | $35,000 | 0.0% | 1,100 | -29.9% | 0.00% | 0.0% |
| Q1 2021 | $35,000 | -31.4% | 1,570 | -39.6% | 0.00% | -50.0% |
| Q4 2020 | $51,000 | -83.4% | 2,598 | -72.8% | 0.00% | -33.3% |
| Q3 2020 | $308,000 | +1000.0% | 9,554 | +890.1% | 0.00% | +200.0% |
| Q2 2020 | $28,000 | +7.7% | 965 | +3.3% | 0.00% | -50.0% |
| Q4 2019 | $26,000 | – | 934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $58,747,000 | 54.16% |
| KPCB XV Associates, LLC | 1,297,063 | $47,641,000 | 37.58% |
| Ponoi II Management, LLC | 145,401 | $5,341,000 | 9.70% |
| Euclidean Capital LLC | 432,900 | $15,900,000 | 9.04% |
| Column Group LLC | 1,402,008 | $51,496,000 | 7.00% |
| AJU IB Investment Co., Ltd. | 99,503 | $3,655,000 | 5.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $42,178,000 | 4.85% |
| Ghost Tree Capital, LLC | 350,000 | $12,856,000 | 4.61% |
| Velan Capital Investment Management LP | 110,000 | $4,040,000 | 3.14% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $16,294,000 | 2.28% |